Evaluation of the isoniazid preventive therapy (IPT) program in Shurugwi District, Midlands Province, Zimbabwe, January 2013 to August 2014

被引：15
作者：
Makoni A. [1 ]
Chemhuru M. [2 ]
Tshimanga M. [1 ]
Gombe N.T. [1 ]
Mungati M. [1 ]
Bangure D. [1 ]
机构：
[1] Department of Community Medicine, University of Zimbabwe, Office 3-66 Kaguvi Building, Cnr 4th/Central Avenue, Harare
[2] Ministry of Health and Child Care, Harare
来源：
BMC Research Notes | / 8卷 / 1期
关键词：
IPT program evaluation; Midlands Province; Shurugwi District;
D O I：
10.1186/s13104-015-1451-y
中图分类号：
学科分类号：
摘要：
Background: Midlands Province started implementing the Isoniazid (INH) preventive therapy (IPT) program in January 2013. Shurugwi and Gokwe North were the piloting district hospitals. In May 2014, four more districts hospitals (Gokwe South, Gweru, Kwekwe and Zvishavane) started implementing IPT. Shurugwi District decentralized the program to its rural health facilities in January 2014. A review of the Shurugwi IPT program, 2013 data, indicated that the majority of eligible clients were not started on IPT. None out of the 400 eligible clients were started on IPT in November against the 100 % target according to the World Health Organization and the National Tuberculosis (TB) Program. We conducted a study to evaluate the IPT program in Shurugwi District from January 2013 to August 2014. Methods: The logical framework approach was used to evaluate inputs, processes, outputs and outcomes of the IPT program. An interviewer administered questionnaire was used to collect data from key informants. Checklists were used to collect data from IPT program records. Results: Sixteen health facilities were implementing IPT in Shurugwi District. All the facilities had TB screening tools and three did not have TB screening algorithms. The district experienced medicine stock outs in 2013. One formal training at district level and on job trainings in implementing health facilities were done. From January 2013 to August 2014, Shurugwi District screened 6794 antiretroviral (ART) clients for TB. Out of those screened, 5255 were eligible for IPT and 2831 (54 %) were started on IPT. A total of 700 clients had completed the IPT 6 month's course by August 2014. The dropout rate due to INH toxicity and TB was 0.6 % (n = 18) and 0.3 % (n = 8) respectively. Fifty-three advocacy and community sensitization meetings were done. The program had no Information Education and Communication (IEC) materials. Conclusion: The IPT program in Shurugwi District achieved half its target. This could be due to inadequate formally trained staff, lack of IEC materials, inadequate advocacy and community sensitization, non-availability of the INH 300 mg single dose and inadequate INH 100 mg dose tablets in 2013. To improve the IPT program, there is need for routine advocacy, communication and social mobilization. © 2015 Makoni et al.
引用
收藏
相关论文
共 12 条
  • [1] Hart L., Isoniazid Preventive Therapy for the Prevention of Tuberculosis in People Living with HIV and AIDS, (2011)
  • [2] Cohen T., Lipsitch M., Walensky R.P., Murray M., Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis co-infected populations, Proc Natl Acad Sci U S A., 103, 18, pp. 7042-7047, (2006)
  • [3] A Guide to Monitoring and Evaluation for Collaborative TB/HIV Activities, pp. 26-27, (2009)
  • [4] World Health Organization Guidelines for Intensified Tuberculosis Case Finding and Isoniazid Preventive Therapy for People Living with HIV in Resource-Constrained Settings, (2011)
  • [5] Progress Report for the Collaborative TB/HIV Activities Supported under the WHO/UBRAF Grant
  • [6] Midlands Province, IPT Review Meeting Presentation, (2014)
  • [7] Indumathi C.K., Gurinder K., Sethuraman A., Iyengar A., Et al., Evaluation of efficacy and adherence to INH preventive therapy in children at risk to develop active tuberculosis, Pediatr Infect Dis., 6, 1, pp. 21-24, (2014)
  • [8] Durovni B., Saraceni V., Moulton L.H., Et al., Tuberculosis Screening and Isoniazid Preventive Therapy Implementation: A Brazilian Experience, 12, 3, pp. 289-292, (2014)
  • [9] Getahuna H., Granich R., Sculier D., Gunneberg C., Blanc L., Nunn P., Raviglione M., Implementation of isoniazid preventive therapy for people living with HIV worldwide: Barriers and solutions, AIDS., 24, pp. S57-S65, (2010)
  • [10] The Three i'S for TB/HIV: Isoniazid Preventive Therapy (IPT), (2014)
12